Showing 3 posts by James (Jim) A. Dietz.
November 1 was the “last chance” for the Centers for Medicare and Medicaid Services (CMS) to issue rules the agency wants to see in effect on January 1 of the following year. Read More ›
“Tort reform” has been a buzzword in the news and legal communities for some time. What does it mean? Generally speaking, it is an effort under state law to limit or mitigate the amounts paid in personal injury and medical malpractice lawsuits. Read More ›
Kentucky providers with prescriptive authority take note: beginning June 29, 2017, new laws (HB 333) go into effect that significantly impact the prescribing of Schedule II drugs. Schedule II drugs include brand names such as Demerol, OxyContin and Percocet. Read More ›
Ask the Blogger
Do you have a topic that you would like discussed in a future blog article? Please let us know. If you have a confidential question regarding a blog article, please feel free to contact the article's author directly, or let us know if you would like for someone to contact you directly.
Brian F. Higgins is an associate in FBT's regulated business group with a focus on health care, and he has a history as corporate counsel to Medpace, Inc., a pharmaceutical clinical research organization.